Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Phase I Study of Intraperitoneal Administration of Paclitaxel Combined with S-1 Plus Cisplatin for Gastric Cancer with Peritoneal Metastasis.

Kobayashi D, Ishigami H, Kanda M, Tanaka C, Yamaguchi H, Kitayama J, Kodera Y.

Oncology. 2019 Sep 5:1-5. doi: 10.1159/000502484. [Epub ahead of print]

PMID:
31487733
2.

[Multidisciplinary treatment for gastric cancer with peritoneal metastasis].

Ishigami H, Kitayama J, Yamaguchi H, Emoto S, Watanabe T.

Gan To Kagaku Ryoho. 2012 Dec;39(13):2460-3. Japanese.

PMID:
23235165
3.

[Intraperitoneal Chemotherapy for Peritoneal Metastasis of Gastric Cancer].

Yamaguchi H, Ishigami H, Kitayama J.

Gan To Kagaku Ryoho. 2016 Dec;43(13):2481-2485. Japanese.

PMID:
28028253
4.

Safety of intraperitoneal paclitaxel combined with conventional chemotherapy for colorectal cancer with peritoneal carcinomatosis: a phase I trial.

Murono K, Nagata H, Ishimaru K, Emoto S, Kaneko M, Hiyoshi M, Sasaki K, Otani K, Shuno Y, Nishikawa T, Tanaka T, Hata K, Kawai K, Nozawa H, Muro K, Ishihara S.

Cancer Chemother Pharmacol. 2019 Jan;83(1):145-150. doi: 10.1007/s00280-018-3714-5. Epub 2018 Nov 1.

PMID:
30386886
5.

Phase I pharmacokinetic study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer.

Ishigami H, Kitayama J, Otani K, Kamei T, Soma D, Miyato H, Yamashita H, Hidemura A, Kaisaki S, Nagawa H.

Oncology. 2009;76(5):311-4. doi: 10.1159/000209277. Epub 2009 Mar 20.

PMID:
19299904
6.

[The updated treatment strategy for gastric cancer with peritoneal metastasis].

Ishigami H, Kaisaki S, Kitayama J.

Nihon Geka Gakkai Zasshi. 2012 Jan;113(1):18-21. Japanese.

PMID:
22413551
7.

Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC Trial.

Ishigami H, Fujiwara Y, Fukushima R, Nashimoto A, Yabusaki H, Imano M, Imamoto H, Kodera Y, Uenosono Y, Amagai K, Kadowaki S, Miwa H, Yamaguchi H, Yamaguchi T, Miyaji T, Kitayama J.

J Clin Oncol. 2018 Jul 1;36(19):1922-1929. doi: 10.1200/JCO.2018.77.8613. Epub 2018 May 10.

PMID:
29746229
8.

A phase 2 trial of intravenous and intraperitoneal paclitaxel combined with S-1 for treatment of gastric cancer with macroscopic peritoneal metastasis.

Yamaguchi H, Kitayama J, Ishigami H, Emoto S, Yamashita H, Watanabe T.

Cancer. 2013 Sep 15;119(18):3354-8. doi: 10.1002/cncr.28204. Epub 2013 Jun 24.

9.

S-1 plus intravenous and intraperitoneal Paclitaxel for gastric cancer with peritoneal metastasis.

Kitayama J, Ishigami H, Yamaguchi H, Yamashita H, Emoto S, Kaisaki S.

Gastrointest Cancer Res. 2012 May;5(3 Suppl 1):S10-3.

10.

Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings.

Ishigami H, Yamaguchi H, Yamashita H, Asakage M, Kitayama J.

Gastric Cancer. 2017 Mar;20(Suppl 1):128-134. doi: 10.1007/s10120-016-0684-3. Epub 2016 Dec 27.

PMID:
28028665
11.

DCF intraperitoneal and intravenous dual chemotherapy regimen for advanced gastric cancer: A feasibility study.

Feng ZL, Chen LB, Liu ZY, Chen XJ, Ren XC, Liu YE, Peng Y, Wang HG, Ma SM, Meng FJ, Lin Q.

Oncol Lett. 2015 Jan;9(1):491-497. Epub 2014 Oct 31.

12.

Oral vinorelbine/paclitaxel combination treatment of metastatic breast cancer: a phase I study.

Delva R, Pienkowski T, Tubiana N, Vanhoefer U, Longerey B, Douville I.

Cancer Chemother Pharmacol. 2007 May;59(6):703-9. Epub 2006 Sep 22.

PMID:
17021821
13.

Cisplatin-epirubicin-paclitaxel weekly administration in advanced breast cancer: a phase I study of the Southern Italy Cooperative Oncology Group.

Frasci G, D'Aiuto G, Comella P, Apicella A, Thomas R, Capasso I, Di Bonito M, Cartenì G, Biglietto M, De Lucia L, Maiorino L, Piccolo S, Bianchi U, D'Aniello R, Lapenta L, Comella G.

Breast Cancer Res Treat. 1999 Aug;56(3):239-52.

PMID:
10573115
14.

A phase I study of IV doxorubicin plus intraperitoneal (IP) paclitaxel and IV or IP cisplatin in endometrial cancer patients at high risk for peritoneal failure (GOG 9920): an NRG Oncology/Gynecologic Oncology Group study.

McMeekin DS, Sill MW, Walker JL, Moore KN, Waggoner SE, Thaker PH, Rizack T, Hoffman JS, Fracasso PM.

Gynecol Oncol. 2015 Jul;138(1):36-40. doi: 10.1016/j.ygyno.2015.04.038. Epub 2015 May 6.

15.

Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites.

Kitayama J, Ishigami H, Yamaguchi H, Yamashita H, Emoto S, Kaisaki S, Watanabe T.

Ann Surg Oncol. 2014 Feb;21(2):539-46. doi: 10.1245/s10434-013-3208-y. Epub 2013 Aug 22.

PMID:
23975319
16.

A phase-I study evaluating the combination of pegylated liposomal doxorubicin and paclitaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracycline.

Hong RL, Lin CH, Chao TY, Kao WY, Wang CH, Hsieh RK, Hwang WS.

Cancer Chemother Pharmacol. 2008 Apr;61(5):847-53. Epub 2007 Jul 4.

PMID:
17609947
17.

A phase II trial of perioperative chemotherapy involving a single intraperitoneal administration of paclitaxel followed by sequential S-1 plus intravenous paclitaxel for serosa-positive gastric cancer.

Peng YF, Imano M, Itoh T, Satoh T, Chiba Y, Imamoto H, Tsubaki M, Nishida S, Yasuda T, Furukawa H.

J Surg Oncol. 2015 Jun;111(8):1041-6. doi: 10.1002/jso.23928. Epub 2015 Jun 7.

PMID:
26060133
18.

A phase I study with an expanded cohort to assess feasibility of intravenous docetaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with previously untreated ovarian, fallopian tube or primary peritoneal carcinoma: a Gynecologic Oncology Group study.

Gould N, Sill MW, Mannel RS, Thaker PH, DiSilvestro PA, Waggoner SE, Yamada SD, Armstrong DK, Fracasso PM, Walker JL.

Gynecol Oncol. 2012 Dec;127(3):506-10. doi: 10.1016/j.ygyno.2012.08.037. Epub 2012 Aug 31.

19.

Breakthrough therapy for peritoneal carcinomatosis of gastric cancer: Intraperitoneal chemotherapy with taxanes.

Yamaguchi H, Kitayama J, Ishigami H, Kazama S, Nozawa H, Kawai K, Hata K, Kiyomatsu T, Tanaka T, Tanaka J, Nishikawa T, Otani K, Yasuda K, Ishihara S, Sunami E, Watanabe T.

World J Gastrointest Oncol. 2015 Nov 15;7(11):285-91. doi: 10.4251/wjgo.v7.i11.285. Review.

20.

[Multidisciplinary treatment strategy for gastric cancer with peritoneal metastasis].

Ishigami H, Kitayama J, Yamaguchi H, Emoto S, Watanabe T.

Gan To Kagaku Ryoho. 2013 Oct;40(10):1269-73. Review. Japanese.

PMID:
24105049

Supplemental Content

Support Center